NCT06097962 2026-03-20Safety and Efficacy of NK510 to Treat NSCLCBase Therapeutics (Shanghai) Co., Ltd.Phase EARLY_PHASE1 Recruiting12 enrolled
NCT04684459 2024-10-30Dual-targeting HER2 and PD-L1 CAR-T for Solid TumorsSichuan UniversityPhase EARLY_PHASE1 Recruiting18 enrolled